What Ketoprofene Li Ta Treats: Main Uses and Benefits

The medication is commonly used to help manage symptom clusters related to physical discomfort, inflammatory states, and systemic imbalance. It is generally applied in contexts where short-term symptomatic assistance is needed, relevant in clinical settings marked by heightened patient distress. This medication is commonly used to ease pain, tenderness, swelling, and stiffness associated with inflammatory conditions.

The medication is relevant for easing symptoms across conditions characterized by periods of heightened symptoms, such as Osteoarthritis, Rheumatoid Arthritis, gout flares, and Primary Dysmenorrhea (menstrual pain). It is also commonly applied in scenarios where additional management of discomfort is required after sprains, strains, or post-operative procedures, and for systemic symptoms like fever and general headaches or muscle aches.

“It provides support that helps ease the overall symptom burden, assisting with maintaining functional stability when symptoms interfere with routine activities.”

This may assist with maintaining functional stability and supports general well-being during symptomatic periods.

---

Quick Fact: Symptomatic Support in Acute Episodes

Ketoprofene Li Ta is often used when symptoms intensify and supportive relief is needed. It is used for managing symptoms that interfere with daily comfort, including those related to inflammatory or irritative states in conditions that involve episodic or fluctuating manifestations.

Regulatory References

1. NIH MedlinePlus Drug Information

Eligibility Profile: Who Can and Cannot Use Ketoprofen

Official regulatory information defines the eligibility for Ketoprofen (including products like Ketoprofene Li Ta) based on patient conditions and specific populations.

Contraindications (Must Not Use):

• Patients with a known hypersensitivity or allergy to ketoprofen, aspirin, or other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), including those with aspirin-sensitive asthma.
• Patients with active gastrointestinal bleeding, ulceration, or perforation, or a history of these severe GI events.
• Patients receiving treatment for peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.
• Women in the third trimester of pregnancy (30 weeks gestation onward).

Restricted or Conditional Use (Use with Caution and Monitoring):

• Pediatric Population: Safety and effectiveness have generally not been established in children.
• Elderly Patients: Use requires caution due to a higher risk for serious gastrointestinal and cardiovascular events, and potential age-related kidney problems.
• Patients with Organ Impairment: Dose adjustments and careful monitoring are required for patients with documented renal (kidney) or hepatic (liver) impairment.
• Pregnancy and Lactation: Use is not recommended for women who are breastfeeding or starting from the 20th week of pregnancy.

Interactions with other medicines and products

Ketoprofen's interaction profile is officially documented to involve risks stemming from pharmacodynamic reinforcement and altered systemic exposure, strictly as defined in government regulatory information. All statements reflect documented interaction patterns and restrictions.

Contraindicated and Strictly Avoided Combinations

• Use is contraindicated in the setting of perioperative pain for Coronary Artery Bypass Graft (CABG) surgery.
• Co-administration is contraindicated in patients with a history of allergic-type reactions following the use of aspirin or other NSAIDs.
• Co-use with other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is officially discouraged due to a high additive risk of gastrointestinal adverse effects.

Clinically Significant Interactions

Interaction Type	Interacting Substance/Class	Official Regulatory Statement
Bleeding Risk (Pharmacodynamic)	Oral Anticoagulants (e.g., Warfarin), Antiplatelet Agents	Increases the risk of serious bleeding and hemorrhage.
Exposure Alteration (Reduced Clearance)	Lithium, Methotrexate	Decreases the renal clearance of these substances, leading to increased plasma concentrations.
Renal/Antihypertensive Risk	Diuretics, ACE Inhibitors, ARBs	May reduce the antihypertensive effect and increases the risk of nephrotoxicity.

Interactions with Other Substances

Consumption of Alcohol is documented to increase the risk of gastrointestinal ulceration and hemorrhage. Certain herbal products (e.g., Ginkgo, Garlic) may also increase the risk of bleeding. Elderly patients are noted to be at a greater risk for serious adverse events when Ketoprofen is combined with interacting drugs.

Core Mechanism: Enzyme and Pathway Modulation

Ketoprofen's action is fundamentally based on the reversible, non-selective inhibition of the Cyclooxygenase ( COX) enzymes, specifically the constitutive COX-1 and the inducible COX-2 isoforms. By occupying the active site of these enzymes, the molecule interrupts the conversion of arachidonic acid into prostanoids, primarily prostaglandins ( PGE2). This enzymatic blockade reduces the overall concentration of these key mediators, resulting in a reduced physiological response at the tissue level.

Cascade Effect and Systemic Signaling

The reduction of PGE2 results in decreased sensitization of peripheral nociceptors and acts centrally within the hypothalamus to reset the body's temperature set point to basal levels. The active component also modulates serotonergic pathways in the Central Nervous System (CNS), contributing to the overall spectrum of its mechanistic activity. This mechanism is functionally constrained by its non-selective nature, which concurrently reduces protective, homeostatic prostaglandins produced by COX-1.

How to Use Ketoprofene Li Ta

Ketoprofene Li Ta is administered using specific patterns to ensure consistent application. The administration is fundamentally divided into two routes: oral for systemic action and topical for localized effect.

Official Dosing and Frequency Patterns

Oral administration involves both immediate-release (IR) and extended-release (ER) capsules. For conditions like arthritis, the standard oral IR regimen is typically 75 mg three times daily or 50 mg four times daily, with the maximum total daily dose limited to 300 mg. The ER form is generally dosed at 200 mg once daily. For acute pain or dysmenorrhea, the IR form is often taken in doses of 25 mg to 50 mg as needed. Topical formulations, such as gels, are applied locally two to four times daily, using approximately a 5 cm to 10 cm strip for each application, which must be massaged into the skin.

Administration Conditions and Adjustments

Oral administration of IR capsules may be done with food, milk, or an antacid to minimize potential gastrointestinal discomfort. Extended-release capsules must not be crushed or chewed to preserve their release profile. Topical application requires specific constraints: the gel must be applied to intact skin, and the treated area must be protected from direct sunlight or UV light during use and for a period after discontinuation. For specific populations, including older adults and patients with hepatic or renal impairment, guidance indicates that a lower initial dose and a lower maximum daily dose should be used.

Research Evidence / Overview of Studies for Ketoprofene Li Ta

This section outlines the structure of the clinical research that has evaluated Ketoprofene Li Ta (Ketoprofen), detailing the types of studies conducted and what findings were reported in authoritative scientific literature. This information provides context on the evidence base but does not constitute medical advice or predict individual patient response.

Evidence for use in Chronic Inflammatory Joint Conditions

Research examining studies conducted in populations with chronic conditions such as Rheumatoid Arthritis and Osteoarthritis has focused on Randomized Controlled Trials (RCTs) and meta-analyses. These studies explored the medication relative to measures of pain, stiffness, and functional status. Trials reported measurements of change in scores during the study period. Findings described patterns observed that were distinct from the measurements recorded in the placebo control group, providing observations of symptomatic patterns. Long-term effects regarding maintenance of functional scores beyond six months are not fully established.

Evidence for use in Acute and Episodic Conditions

The evidence base for acute painful episodes (e.g., post-operative pain, sprains) is built on highly structured single-dose RCTs and Systematic Reviews. These studies monitored outcomes describing episodic changes, such as the measured onset of symptomatic change and the frequency of subsequent analgesic use. Research has explored the use of both oral and topical forms (gels/solutions) in these contexts, focusing on changes in local pain and joint mobility. Separately, crossover trials have monitored changes in pain intensity scores during the symptomatic phase of Primary Dysmenorrhea.

What is Still Uncertain About the Research for Ketoprofene Li Ta

The available evidence, based on comparisons across studies, has specific research gaps. Data for certain groups remain insufficient, particularly for long-term use in all chronic indications. Comparative evidence is lacking between the topical and oral systemic forms in patients with deeper joint issues. Furthermore, follow-up durations were limited in many trials, meaning the research provides limited information for long-term outcomes related to structural or progressive changes in chronic conditions. Research is ongoing to fill these knowledge gaps.

Common questions about Ketoprofene Li Ta (FAQ)

Q: What is Ketoprofene Li Ta and what is its approved use?

Ketoprofene Li Ta is a non-steroidal anti-inflammatory drug (NSAID). It is indicated for use in managing pain and inflammation associated with conditions such as rheumatoid arthritis, osteoarthritis, and menstrual discomfort. The specific indications are based on regulatory approval.

---

Q: How does Ketoprofene Li Ta generally function in the body?

Ketoprofene Li Ta is understood to act by interfering with certain chemical messengers in the body, which are involved in the process of generating inflammation and pain.

---

Q: Is Ketoprofene Li Ta available over-the-counter or does it require a prescription?

The availability of Ketoprofene Li Ta as an over-the-counter (OTC) medication or a prescription-only drug can vary depending on the strength and the specific regulations in different geographic locations. A healthcare provider can offer guidance on its status.

---

Q: What are common side effects associated with Ketoprofene Li Ta?

As with many medications, use of Ketoprofene Li Ta has been observed to be associated with certain side effects. Common reported events may involve the gastrointestinal system, such as nausea or indigestion. It is important to discuss the potential for side effects with a qualified healthcare professional.

Official Storage and Disposal Requirements

Storage Conditions and Handling

Ketoprofene Li Ta must be stored at Controlled Room Temperature (typically 20 C to 25 C). The product must be protected from both light and moisture, requiring the container to be kept tightly closed in its original packaging.

It is strictly required not to freeze or refrigerate this medicine, and exposure to excessive heat must be avoided. For safety, always store the medicine out of the sight and reach of children.

Disposal Protocol

Unused or expired Ketoprofene Li Ta must not be disposed of in household trash or poured down a sink or toilet. Official regulatory guidelines recommend disposing of the medicine through a drug take-back program or a designated collection point. Disposal must adhere to local environmental and pharmaceutical waste regulations.